122 related articles for article (PubMed ID: 29461302)
1. Does initial use of benzodiazepines delay an adequate pharmacological treatment? A multicentre analysis in patients with psychotic and affective disorders.
Grancini B; De Carlo V; Palazzo M; Vismara M; Arici C; Cremaschi L; Benatti B; Altamura AC; Dell'Osso B
Int Clin Psychopharmacol; 2018 May; 33(3):140-146. PubMed ID: 29461302
[TBL] [Abstract][Full Text] [Related]
2. Exploring characteristics associated with first benzodiazepine prescription in patients with affective disorders and related diagnoses.
De Carlo V; Grancini B; Vismara M; Benatti B; Arici C; Cremaschi L; Cirnigliaro G; Degoni L; Oldani L; Palazzo C; Glick ID; Viganò C; Dell'Osso B
Hum Psychopharmacol; 2019 May; 34(3):e2695. PubMed ID: 31044486
[TBL] [Abstract][Full Text] [Related]
3. Factors characterizing access and latency to first pharmacological treatment in Italian patients with schizophrenia, mood, and anxiety spectrum disorders.
Dell'Osso B; Cremaschi L; Palazzo C; Suardi N; Spagnolin G; Camuri G; Benatti B; Oldani L; Dobrea C; Arici C; Pace G; Tiseo A; Nahum ES; Castellano F; D'Urso N; Clerici M; Primavera D; Carpiniello B; Altamura AC
Int Clin Psychopharmacol; 2015 Jan; 30(1):29-35. PubMed ID: 25117878
[TBL] [Abstract][Full Text] [Related]
4. [The problems with the use of benzodiazepines in elderly patients].
Bourin M
Encephale; 2010 Sep; 36(4):340-7. PubMed ID: 20850606
[TBL] [Abstract][Full Text] [Related]
5. High dose benzodiazepines prolong reaction times in chronic users who have major depressive and/or anxiety disorders.
Manthey L; van Loenen-Frösch F; Giltay EJ; van Veen T; Glashouwer K; Penninx BW; Zitman FG
Br J Clin Pharmacol; 2014 Mar; 77(3):571-7. PubMed ID: 23962205
[TBL] [Abstract][Full Text] [Related]
6. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD).
Demyttenaere K; Bonnewyn A; Bruffaerts R; De Girolamo G; Gasquet I; Kovess V; Haro JM; Alonso J
J Affect Disord; 2008 Sep; 110(1-2):84-93. PubMed ID: 18329721
[TBL] [Abstract][Full Text] [Related]
7. Reduced duration of untreated illness over time in patients with schizophrenia spectrum, mood and anxiety disorders.
Dell'Osso B; Oldani L; Camuri G; Benatti B; Grancini B; Arici C; Cremaschi L; Palazzo M; Spagnolin G; Dobrea C; Altamura AC
Psychiatry Clin Neurosci; 2016 May; 70(5):202-10. PubMed ID: 26821781
[TBL] [Abstract][Full Text] [Related]
8. A study of benzodiazepine users claiming drug-induced psychiatric morbidity.
Mattila-Evenden M; Bergman U; Franck J
Nord J Psychiatry; 2001; 55(4):271-8. PubMed ID: 11839118
[TBL] [Abstract][Full Text] [Related]
9. Perceptions, clinical characteristics, and other factors associated with prolonged and high daily dose of benzodiazepine use among patients with anxiety or depressive disorders.
Chen YT; Liu CY; Chang CM; Lai YM; Wang BH; Yang TY; Hsu SC
J Affect Disord; 2020 Jun; 271():215-223. PubMed ID: 32479319
[TBL] [Abstract][Full Text] [Related]
10. Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.
Stein MD; Kanabar M; Anderson BJ; Lembke A; Bailey GL
J Subst Abuse Treat; 2016 Sep; 68():57-61. PubMed ID: 27431047
[TBL] [Abstract][Full Text] [Related]
11. Alcohol consumption among Canadians taking benzodiazepines and related drugs.
Veldhuizen S; Wade TJ; Cairney J
Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):203-10. PubMed ID: 19115421
[TBL] [Abstract][Full Text] [Related]
12. Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder.
Stein MD; Anderson BJ; Kenney SR; Bailey GL
J Subst Abuse Treat; 2017 Jun; 77():67-71. PubMed ID: 28476275
[TBL] [Abstract][Full Text] [Related]
13. Correlates of (inappropriate) benzodiazepine use: the Netherlands Study of Depression and Anxiety (NESDA).
Manthey L; van Veen T; Giltay EJ; Stoop JE; Neven AK; Penninx BW; Zitman FG
Br J Clin Pharmacol; 2011 Feb; 71(2):263-72. PubMed ID: 21219408
[TBL] [Abstract][Full Text] [Related]
14. Benzodiazepine tapering: a prospective study.
Vikander B; Koechling UM; Borg S; Tönne U; Hiltunen AJ
Nord J Psychiatry; 2010 Aug; 64(4):273-82. PubMed ID: 20629611
[TBL] [Abstract][Full Text] [Related]
15. Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic.
Kitajima R; Miyamoto S; Tenjin T; Ojima K; Ogino S; Miyake N; Fujiwara K; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Kaneda Y; Yamaguchi N
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):300-6. PubMed ID: 22122880
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of generalized anxiety: new pharmacologic approaches].
Boulenger JP
Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
[TBL] [Abstract][Full Text] [Related]
17. Dependence on prescription benzodiazepines and Z-drugs among young to middle-aged patients in France.
Guerlais M; Grall-Bronnec M; Feuillet F; Gérardin M; Jolliet P; Victorri-Vigneau C
Subst Use Misuse; 2015 Feb; 50(3):320-7. PubMed ID: 25474727
[TBL] [Abstract][Full Text] [Related]
18. Patterns and correlates of benzodiazepine use in the French general population.
Lagnaoui R; Depont F; Fourrier A; Abouelfath A; Bégaud B; Verdoux H; Moore N
Eur J Clin Pharmacol; 2004 Sep; 60(7):523-9. PubMed ID: 15338086
[TBL] [Abstract][Full Text] [Related]
19. Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature.
Petrovic M; Mariman A; Warie H; Afschrift M; Pevernagie D
Acta Clin Belg; 2003; 58(1):27-36. PubMed ID: 12723259
[TBL] [Abstract][Full Text] [Related]
20. Correlates of benzodiazepine dependence in the Netherlands Study of Depression and Anxiety.
Manthey L; Lohbeck M; Giltay EJ; van Veena T; Zitman FG; Penninx BW
Addiction; 2012 Dec; 107(12):2173-82. PubMed ID: 22703562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
